Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chloride channel protein ClC-Ka (CLCNKA) is a voltage-gated chloride channel primarily expressed in the kidneys and inner ear. In the kidneys, it mediates transepithelial chloride transport, crucial for salt reabsorption, fluid balance, and blood pressure regulation. In the inner ear, it contributes to potassium recycling essential for hearing function. It requires the barttin beta subunit for functional expression. Variants may be associated with salt-sensitive hypertension.
Voltage-gated chloride channel activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chloride channel protein ClC-Ka (ClC-Ka).